Overview

  • Product name
    Bromocriptine mesylate
  • Description
    Potent, selective D2-like dopamine receptor agonist
  • Biological description
    Potent, selective D2-like dopamine receptor agonist (Ki values are ~8 (D2), ~5 (D3), ~290 (D4), ~440 (D1) and ~450 nM (D5)). Inhibits the release of pituitary prolactin and stimulates motor activity in Parkinson's disease. Also reverses glutamate transporter 1 (GLT-1) activity, increasing glutamate levels.
  • Purity
    > 99%

Properties

References

This product has been referenced in:
  • Shirasaki Y  et al. Bromocriptine, an ergot alkaloid, inhibits excitatory amino acid release mediated by glutamate transporter reversal. Eur J Pharmacol 643:48-57 (2010). Read more (PubMed: 20599932) »
  • Lindgren HS  et al. Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease. Neuropsychopharmacology 34:2477-88 (2009). Read more (PubMed: 19606087) »
  • Valente D  et al. Metabolite involvement in bromocriptine-induced prolactin inhibition in rats. J Pharmacol Exp Ther 282:1418-24 (1997). Read more (PubMed: 9316855) »
  • Seeman P & Van Tol HH Dopamine receptor pharmacology. Trends Pharmacol Sci 15:264-70 (1994). Read more (PubMed: 7940991) »

See 0 Publications for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab120574.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up